BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 17943811)

  • 1. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
    Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study.
    Ahmed M; Bell T; Lawrence WT; Ward JP; Watson GM
    Br J Urol; 1997 Feb; 79(2):181-5. PubMed ID: 9052467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Macdonald R; Rutks I
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD002081. PubMed ID: 21901681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia (BPH)--our first 100 cases.
    Lee KT; Tan HH; Li MK; Cheng WS; Rekhraj IR; Foo KT
    Singapore Med J; 1995 Apr; 36(2):181-4. PubMed ID: 7545827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up.
    Dahlstrand C; Waldén M; Geirsson G; Pettersson S
    Br J Urol; 1995 Nov; 76(5):614-8. PubMed ID: 8535682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thermotherapy of benign prostatic hyperplasia].
    Höfner K; Krah H; Tan HK; Kuczyk M; Jonas U
    Urologe A; 1995 Jan; 34(1):16-24. PubMed ID: 7533447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.
    Cornu JN; Zantek P; Burtt G; Martin C; Martin A; Springate C; Chughtai B
    Eur Urol; 2023 Jun; 83(6):534-547. PubMed ID: 36964042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia. Practical treatment guidelines.
    Tammela T
    Drugs Aging; 1997 May; 10(5):349-66. PubMed ID: 9143856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT.
    Worthington J; Lane JA; Taylor H; Young G; Noble SM; Abrams P; Ahern A; Brookes ST; Cotterill N; Johnson L; Khan R; Fernandez AM; Page T; Swami S; Hashim H
    Health Technol Assess; 2020 Sep; 24(41):1-96. PubMed ID: 32901611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Terazosin for benign prostatic hyperplasia.
    Wilt TJ; Howe RW; Rutks I; Macdonald R
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD003851. PubMed ID: 21901686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transurethral microwave-thermotherapy in the treatment of benign prostatic hyperplasia].
    de Wildt MJ; de la Rosette JJ; Froeling FM; Bloem FA; Laduc R; Debruyne FM
    Ned Tijdschr Geneeskd; 1994 Aug; 138(35):1764-70. PubMed ID: 7523961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study.
    Dahlstrand C; Geirsson G; Fall M; Pettersson S
    Eur Urol; 1993; 23(2):292-8. PubMed ID: 7683989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the prostate weight in transurethral microwave thermotherapy.
    Netto Júnior NR; de Lima ML; Claro Jde A; de Andrade EF
    Arch Esp Urol; 1995 May; 48(4):413-7. PubMed ID: 7541194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transurethral microwave thermotherapy for benign prostatic hyperplasia].
    Kawamura K; Kikuyama A; Moriyama M; Nakajima C; Shiba N; Kobayashi S; Magome A; Kido C; Miyazawa K; Tanaka T
    Hinyokika Kiyo; 1993 Nov; 39(11):993-6. PubMed ID: 7505524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transurethral microwave thermotherapy for benign prostatic hyperplasia].
    Tokumitsu M; Mizunaga M; Kaneko S; Kitahara K; Kawakami N; Tsurukawa H; Noda T; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):670-6. PubMed ID: 9267131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral microwave thermotherapy versus transurethral catheter therapy for benign prostatic hyperplasia.
    Mulvin D; Creagh T; Kelly D; Smith J; Quinlan D; Fitzpatrick J
    Eur Urol; 1994; 26(1):6-9. PubMed ID: 7523132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: preliminary experience.
    Van Cauwelaert RR; Castillo OC; Aquirre CA; Azocar GH; Medina FI
    Eur Urol; 1993; 23(2):282-4. PubMed ID: 7683987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.